Nanoporous graphene-based thin-film microelectrodes for in vivo high-resolution neural recording and stimulation
Institut Català de Nanociència i Nanotecnologia · Instituto de Salud Carlos III · +13 more institutions
Abstract
Abstract One of the critical factors determining the performance of neural interfaces is the electrode material used to establish electrical communication with the neural tissue, which needs to meet strict electrical, electrochemical, mechanical, biological and microfabrication compatibility requirements. This work presents a nanoporous graphene-based thin-film technology and its engineering to form flexible neural interfaces. The developed technology allows the fabrication of small microelectrodes (25 µm diameter) while achieving low impedance (∼25 kΩ) and high charge injection (3–5 mC cm − 2 ). In vivo brain recording performance assessed in rodents reveals high-fidelity recordings (signal-to-noise ratio…
Citation impact
- FWCI
- 28.93
- Percentile
- 100%
- References
- 63
Authors
32- DVDamià VianaCorresponding
Institut Català de Nanociència i Nanotecnologia
- STSteven T. Walston
Institut Català de Nanociència i Nanotecnologia
- EMEduard Masvidal‐Codina
Institut Català de Nanociència i Nanotecnologia
- XIXavi Illa
Instituto de Salud Carlos III, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine, Institut de Microelectrònica de Barcelona
- BRBruno Rodríguez‐Meana
Universitat Autònoma de Barcelona, Biomedical Research Networking Center on Neurodegenerative Diseases, Centro de Investigación Biomédica en Red
Topics & keywords
- Microelectrode
- Materials science
- Microfabrication
- Multielectrode array
- Nanoporous
- Graphene
- Biomedical engineering
- Nanotechnology
Funding
- WTWellcome TrustAward: MCIN/AEI/10.13039/501100011033
- URUK Research and Innovation
- CDCentres de Recerca de CatalunyaAwards: 501100011033, MCIN/AEI/10.13039/501100011033
- ICInstitut Català de Nanociència i NanotecnologiaAward: CEX2021-001214-S
- ECEuropean CommissionAwards: 754510, PRTR-C17.I1, 10.13039/501100011033, 13039/501100011033, 501100011033, 881603, C17.I1, 101070865, AEI/10.13039/501100011033, PRTR-C17, MCIN/AEI/10.13039/501100011033
- GDGeneralitat de CatalunyaAwards: 10.13039/501100011033, PRTR-C17.I1, 501100011033, MCIN/AEI/10.13039/501100011033, 2021SGR00495, 2021SGR00457, MCIN/AEI/10.13039.501100011033, CEX2021-001214-S, PID2019, 754510
- MDMinisterio de Ciencia e InnovaciónAwards: MCIN/AEI/10, 10.13039, PID2019, AEI/10.13039/501100011033, 501100011033, AEI/10, PID2020, PRTR-C17.I1, MCIN/AEI/10., PID2020-, MCIN/AEI/10.13039/501100011033, 10.13039/501100011033, 13039/501100011033, CEX2021-001214-S, 10.13039.501100011033, PRTR-C17, /AEI/10.13039/501100011033, MCIN/AEI/10.13039
- CDCentro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y NanomedicinaAward: CB06/01/0049
- UDUniversidad de Zaragoza
- MDMinisterio de Asuntos Económicos y Transformación Digital, Gobierno de EspañaAwards: 10.13039/501100011033, MCIN/AEI/10.13039/501100011033, AEI/10.13039/501100011033
- UAUniversitat Autònoma de BarcelonaAwards: MCIN/AEI/10.13039/501100011033, 13039/501100011033
- CDCentro de Investigación Biomédica en Red sobre Enfermedades NeurodegenerativasAward: CB06/05/1105
- DFDirectorate for Biological Sciences
- H2Horizon 2020 Framework ProgrammeAward: 881603
- HEHORIZON EUROPE Framework ProgrammeAwards: 881603, 101070865, MCIN/AEI/10.13039/501100011033
- BABiotechnology and Biological Sciences Research Council
- IDInstituto de Salud Carlos IIIAwards: CB06/05/1105, CB06/01/0049, MCIN/AEI/10.13039/501100011033, /10.13039/501100011033, AEI/10.13039/501100011033
- AEAgencia Estatal de InvestigaciónAwards: AEI/10.13039/501100011033, PRTR-C17.I1, 501100011033, CEX2021-001214-S, 10.13039/501100011033, MCIN/AEI/10.13039/501100011033, 13039, MCIN/AEI/10.13039.501100011033, 10.13039, PID2019-104683RB-I00, AEI/10, 13039/501100011033, AEI/10., PID2019, PID2020-113663RB-I00